Switch theme
Sign up to access all valuation multiples
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
2005
73
LTM Revenue $27.4M
Last FY EBITDA -$10.9M
$33.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
electroCore has a last 12-month revenue (LTM) of $27.4M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, electroCore achieved revenue of $25.2M and an EBITDA of -$10.9M.
electroCore expects next 12-month revenue of XXX and NTM EBITDA of XXX
See electroCore valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $27.4M | XXX | $25.2M | XXX | XXX | XXX |
| Gross Profit | $23.2M | XXX | $21.4M | XXX | XXX | XXX |
| Gross Margin | 85% | XXX | 85% | XXX | XXX | XXX |
| EBITDA | n/a | XXX | -$10.9M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -43% | XXX | XXX | XXX |
| EBIT | -$11.2M | XXX | -$12.2M | XXX | XXX | XXX |
| EBIT Margin | -41% | XXX | -48% | XXX | XXX | XXX |
| Net Profit | -$11.2M | XXX | -$11.9M | XXX | XXX | XXX |
| Net Margin | -41% | XXX | -47% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, electroCore's stock price is $5.
electroCore has current market cap of $37.1M, and EV of $33.5M.
See electroCore trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $33.5M | $37.1M | XXX | XXX | XXX | XXX | $-1.44 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, electroCore has market cap of $37.1M and EV of $33.5M.
electroCore's trades at 1.3x EV/Revenue multiple, and -3.1x EV/EBITDA.
Equity research analysts estimate electroCore's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
electroCore has a P/E ratio of -3.3x.
See valuation multiples for electroCore and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $37.1M | XXX | $37.1M | XXX | XXX | XXX |
| EV (current) | $33.5M | XXX | $33.5M | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -3.1x | XXX | XXX | XXX |
| EV/EBIT | -3.0x | XXX | -2.8x | XXX | XXX | XXX |
| EV/Gross Profit | 1.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | -3.3x | XXX | -3.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -4.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialelectroCore's last 12 month revenue growth is 32%
electroCore's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.5M for the same period.
electroCore's rule of 40 is -82% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
electroCore's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for electroCore and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 32% | XXX | 32% | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -43% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -82% | XXX | -12% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 9% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 133% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
electroCore acquired XXX companies to date.
Last acquisition by electroCore was XXXXXXXX, XXXXX XXXXX XXXXXX . electroCore acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was electroCore founded? | electroCore was founded in 2005. |
| Where is electroCore headquartered? | electroCore is headquartered in United States of America. |
| How many employees does electroCore have? | As of today, electroCore has 73 employees. |
| Who is the CEO of electroCore? | electroCore's CEO is Mr. Daniel S. Goldberger. |
| Is electroCore publicy listed? | Yes, electroCore is a public company listed on NAS. |
| What is the stock symbol of electroCore? | electroCore trades under ECOR ticker. |
| When did electroCore go public? | electroCore went public in 2018. |
| Who are competitors of electroCore? | Similar companies to electroCore include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of electroCore? | electroCore's current market cap is $37.1M |
| What is the current revenue of electroCore? | electroCore's last 12 months revenue is $27.4M. |
| What is the current revenue growth of electroCore? | electroCore revenue growth (NTM/LTM) is 32%. |
| What is the current EV/Revenue multiple of electroCore? | Current revenue multiple of electroCore is 1.2x. |
| Is electroCore profitable? | Yes, electroCore is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
